HomeNewsIndiaCoronavirus mutated into 10 types: A2a mutant most effective in transmission, attacking human lung cells

Coronavirus mutated into 10 types: A2a mutant most effective in transmission, attacking human lung cells

The conclusions from the study are important as they will provide those conducting research on prospective vaccines with a specific target

April 28, 2020 / 19:44 IST
Story continues below Advertisement
Representative image
Representative image

The novel coronavirus, officially named SARS-CoV-2, which was first reported from Wuhan in China in December 2019, has mutated into 10 different types, of which one A2a has become dominant and spread across geographical regions, The Times of India has reported.

The newspaper has cited a study conducted by Nidhan Biswas and Partha Majumdar from the National Institute of Biomedical Genomics in West Bengal. The study is going to be published in the Indian Journal of Medical Research, which is a medical journal published by ICMR (Indian Council of Medical Research).

Story continues below Advertisement

According to the study, the A2a mutation of the novel coronavirus is highly efficient in entering human lung cells in large numbers. The previous SARS-CoV, which had emerged in 2010 and infected over 8,000 and killed 800, was also efficient in attacking human lung cells, but it was not as adept as A2a.

Besides, A2a is efficient in transmission, and consequently, it has spread rapidly across the globe, the authors pointed out in their study.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show